Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
|
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
|---|---|---|---|---|---|---|---|---|---|
| TGCT | rs61168067 | chr7:127785074 | C/A | 1.78E-9 | 134 | 42.27 | 37.53 | 12.55 | KM Plot |
| TGCT | rs61238373 | chr2:29494619 | A/G | 0 | 134 | 42.27 | 25.02 | 0.57 | KM Plot |
| TGCT | rs61314551 | chr2:74109549 | A/G | 2.7E-7 | 129 | 40.57 | 95.37 | 22.83 | KM Plot |
| TGCT | rs61392587 | chr2:3944805 | CTT/C | 4.58E-11 | 131 | 46.07 | 40.57 | 13.43 | KM Plot |
| TGCT | rs61525327 | chr5:1799743 | A/C | 1.89E-5 | 132 | 42.27 | 43.9 | 20.6 | KM Plot |
| TGCT | rs61708580 | chr5:1827035 | CCCAGTCCCTGTGGAAGTGA/C | 7.9E-6 | 131 | 42.1 | 48.4 | 24.73 | KM Plot |
| TGCT | rs61772810 | chr1:49038890 | G/A | 1.49E-6 | 128 | 37.2 | 111.63 | 0.57 | KM Plot |
| TGCT | rs61946168 | chr12:129264272 | A/G | 1.89E-5 | 133 | 42.03 | 66.9 | 21.75 | KM Plot |
| TGCT | rs62063760 | chr17:77041619 | G/A | 7.31E-5 | 129 | 46.77 | 36.63 | 18.07 | KM Plot |
| TGCT | rs62063762 | chr17:77042146 | C/T | 7.31E-5 | 129 | 46.77 | 36.63 | 18.07 | KM Plot |
| TGCT | rs62104504 | chr19:30341864 | G/A | 2.74E-6 | 131 | 37.3 | 51.67 | 20.6 | KM Plot |
| TGCT | rs62104507 | chr19:30348996 | C/T | 6.65E-5 | 131 | 37.53 | 48.87 | 29.4 | KM Plot |
| TGCT | rs62153764 | chr2:99818612 | T/G | 2.95E-5 | 131 | 42.1 | 66.9 | 26.4 | KM Plot |
| TGCT | rs62281198 | chr3:172433685 | T/C | 8.19E-5 | 134 | 25.33 | 37.42 | 45.1 | KM Plot |
| TGCT | rs62325142 | chr4:154717790 | A/G | 8.89E-5 | 134 | 40.57 | 49.93 | 50.9 | KM Plot |